Home › Funds › Brendel Financial Advisors LLC › WST

Brendel Financial Advisors LLC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Brendel Financial Advisors LLC reported holding 13,444 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 2.27% of its reported portfolio and ranking #13 among its reported holdings. Brendel Financial Advisors LLC has disclosed WST holdings in 4 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)13.44K sh
Reported value held$4.98M
Portfolio Weight2.27%
First reportedQ4 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Brendel Financial Advisors LLC's WST position evolved

Brendel Financial Advisors LLC first disclosed a stake in WST in Q4 2023 at 7,516 shares (US$2.6M). The position peaked in Q3 2026 at 13,444 shares, worth US$5.0M. Across 4 filings, Brendel Financial Advisors LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 13,444 shares valued at US$5.0M — an increase of 1,553 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 7.52K $2.65M New
Q4 2025 13.60K $3.74M New
Q2 2026 11.89K $4.27M New
Q3 2026 13.44K $4.98M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Brendel Financial Advisors LLC held WST?

Brendel Financial Advisors LLC has disclosed WST holdings in 4 of the last 12 reported quarters, going back to Q4 2023.

What is Brendel Financial Advisors LLC's current position in WST?

As of Q3 2026, Brendel Financial Advisors LLC holds 13.44K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $4.98M, representing 2.27% of its reported portfolio and ranking #13.

Has Brendel Financial Advisors LLC been buying or selling WST?

In the latest 13F filing (Q3 2026), Brendel Financial Advisors LLC increased its position in WST. The position peaked in Q3 2026 at 13.44K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.